IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.923
AS - Asia 15.465
EU - Europa 11.430
SA - Sud America 3.404
AF - Africa 401
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 27
Totale 56.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.475
SG - Singapore 5.409
CN - Cina 5.129
BR - Brasile 2.817
UA - Ucraina 2.782
HK - Hong Kong 1.801
IT - Italia 1.699
DE - Germania 1.605
PL - Polonia 1.094
VN - Vietnam 1.074
FI - Finlandia 949
FR - Francia 777
GB - Regno Unito 604
TR - Turchia 590
RU - Federazione Russa 560
IE - Irlanda 498
IN - India 448
SE - Svezia 309
AR - Argentina 228
BD - Bangladesh 218
CA - Canada 196
MX - Messico 143
IQ - Iraq 131
ZA - Sudafrica 122
ID - Indonesia 106
EC - Ecuador 93
JP - Giappone 88
NL - Olanda 88
CZ - Repubblica Ceca 78
ES - Italia 77
CO - Colombia 73
AT - Austria 71
SA - Arabia Saudita 59
BE - Belgio 57
UZ - Uzbekistan 56
VE - Venezuela 55
AU - Australia 53
PK - Pakistan 48
MA - Marocco 46
EG - Egitto 39
PY - Paraguay 38
MU - Mauritius 35
CL - Cile 33
PE - Perù 31
NG - Nigeria 30
JO - Giordania 28
KE - Kenya 28
AE - Emirati Arabi Uniti 27
EU - Europa 26
IL - Israele 25
AZ - Azerbaigian 24
JM - Giamaica 23
DZ - Algeria 22
TN - Tunisia 22
UY - Uruguay 22
LT - Lituania 19
PH - Filippine 19
CH - Svizzera 18
KR - Corea 18
OM - Oman 18
DK - Danimarca 17
ET - Etiopia 17
NP - Nepal 17
TH - Thailandia 16
IR - Iran 15
PA - Panama 15
RO - Romania 15
SN - Senegal 15
KG - Kirghizistan 14
DO - Repubblica Dominicana 13
GR - Grecia 12
MY - Malesia 12
AL - Albania 11
BO - Bolivia 11
HN - Honduras 11
HU - Ungheria 11
KZ - Kazakistan 11
PT - Portogallo 11
PS - Palestinian Territory 10
BG - Bulgaria 9
CR - Costa Rica 9
LB - Libano 9
TT - Trinidad e Tobago 9
BA - Bosnia-Erzegovina 8
SK - Slovacchia (Repubblica Slovacca) 8
LK - Sri Lanka 7
LV - Lettonia 7
AM - Armenia 6
HR - Croazia 6
NI - Nicaragua 6
AO - Angola 5
BB - Barbados 5
BY - Bielorussia 5
RS - Serbia 5
BH - Bahrain 4
CU - Cuba 4
EE - Estonia 4
GA - Gabon 4
GE - Georgia 4
MN - Mongolia 4
Totale 56.633
Salva come PNG Salva come JPEG
Città #
Singapore 2.788
Woodbridge 2.462
Fairfield 2.431
Ashburn 2.156
Jacksonville 1.974
Hong Kong 1.797
Houston 1.790
Ann Arbor 1.355
Cambridge 1.085
Warsaw 1.075
Wilmington 972
The Dalles 967
Seattle 955
Princeton 935
San Jose 916
Beijing 822
Chandler 799
New York 658
Nanjing 657
Dublin 492
Helsinki 489
Lauterbourg 479
Los Angeles 457
Istanbul 437
Ho Chi Minh City 354
Dallas 350
Munich 334
Des Moines 326
Brescia 312
Nanchang 267
São Paulo 263
Milan 250
Hanoi 229
Shanghai 227
Buffalo 203
Moscow 190
Redondo Beach 177
Changsha 172
San Diego 168
Shenyang 166
Dearborn 148
Tianjin 143
San Francisco 141
Jinan 133
Hebei 129
Boardman 118
Council Bluffs 116
Jiaxing 109
Turku 108
Orem 107
Chicago 104
London 101
Santa Clara 100
Hangzhou 95
Brooklyn 81
Tokyo 78
Verona 78
Kunming 76
Rio de Janeiro 71
Rome 71
Nuremberg 70
Chennai 65
Frankfurt am Main 65
Guangzhou 65
Kocaeli 65
Brasília 63
Denver 61
Atlanta 60
Johannesburg 60
Brno 59
Toronto 59
Zhengzhou 58
Belo Horizonte 57
Brussels 56
Curitiba 54
Pune 54
Montreal 53
Ningbo 49
Boston 47
Romola 47
Tashkent 47
Baghdad 45
Lanzhou 44
Phoenix 44
Stockholm 44
Haiphong 43
Manchester 43
Poplar 41
Mexico City 39
Dong Ket 36
Da Nang 35
Salvador 34
Amsterdam 33
Jakarta 33
Mumbai 33
Norwalk 33
Turin 33
Campinas 31
Guarulhos 31
Porto Alegre 31
Totale 36.963
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 316
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 291
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 290
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 268
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain 263
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges 261
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 246
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 238
Zebrafish disease models in hematology: Highlights on biological and translational impact 233
Do chromosomal abnormalities show up during mesenchymal stromal cell expansion? 229
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 206
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 204
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 203
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 201
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 198
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 188
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 186
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 183
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 182
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 181
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 177
A first update on mapping the human genetic architecture of COVID-19 176
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 176
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 172
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 171
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 170
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 169
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 168
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 167
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 167
Advances in CMV Management: A Single Center Real-Life Experience 167
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 166
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 165
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 164
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 162
Fungemia in hematological malignancies: SEIFEM-2015 survey 161
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 159
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 159
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 157
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. 156
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 155
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 154
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 153
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 153
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 152
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 152
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 152
5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects. 151
Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway. 151
Central nervous system angiitis in Hodgkin's disease. 151
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 151
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 151
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 151
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 151
Screening of Bcr-Abl transcripts in Philadelphia negative essential thrombocythemia. 150
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 150
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. 149
Assessment of Liver Damage with Transient Hepatic Elastography (FIBROSCAN) in patients with chronic Graft-Versus-Host Disease. 148
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 148
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 148
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 148
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 147
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 147
Impedance-based monitoring of mesenchymal stromal cell three-dimensional proliferation using aerosol jet printed sensors: A tissue engineering application 146
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 146
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 144
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 144
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 144
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia 142
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. 141
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 141
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 140
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 140
Advances in the treatment of monoclonal gammapathies: the emerging role of targeted therapy in plasma cell dyscrasias. 139
Laboratory diagnostics of inherited platelet disorders. 139
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 138
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 138
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 138
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 137
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 137
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 137
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma 136
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 136
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 136
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 135
Long-term follow-up of the Italian trial of interferon- versus conventional chemotherapy in chronic myeloid leukemia 135
Laparoscopic splenectomy in the management of hematological diseases 135
Rituximab in a case of cold agglutinin disease 135
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. 135
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. 135
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 135
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 134
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia 134
TRIDIMENSIONAL BIOACTIVE POROUS BODY FOR BONE TISSUE REGENERATION AND PROCESS FOR ITS PREPARATION 134
INTEGRATED CORE-SHELL BIOACTIVE STRUCTURE FOR THE REGENERATION OF BONE AND OSTEOCHONDRAL TISSUES 134
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. 133
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia 133
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 133
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 133
Expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation: ongoing results of a prospective study. 131
Totale 16.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.552 0 0 0 0 0 0 0 0 0 702 597 253
2021/20223.524 201 575 66 244 107 233 171 266 198 441 274 748
2022/20232.713 571 96 68 211 213 725 13 229 318 35 105 129
2023/20243.469 162 75 233 168 151 598 159 140 953 41 64 725
2024/20258.648 76 93 95 972 922 700 731 274 1.097 685 1.684 1.319
2025/202617.622 1.558 2.529 1.591 2.962 1.579 1.359 2.598 871 1.237 1.338 0 0
Totale 57.791